• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Investigating Bacterial Motion for New Treatment Strategies

      Investigating Bacterial Motion for New Treatment Strategies

      Smart Sutures Sense Inflammation, Deliver Drugs, Cells

      Smart Sutures Sense Inflammation, Deliver Drugs, Cells

      siRNA as a COVID-19 Treatment

      siRNA as a COVID-19 Treatment

      Cancer Organoids Offer Insights into Treatment Outcomes

      Cancer Organoids Offer Insights into Treatment Outcomes

    • Radiology
      Implanted Ultrasound Lets Chemo Access Brain

      Implanted Ultrasound Lets Chemo Access Brain

      Wearable Ultrasound Measures Tissue Stiffness Under Skin

      Wearable Ultrasound Measures Tissue Stiffness Under Skin

      Brain Decoder Spells Out Thoughts

      Brain Decoder Spells Out Thoughts

      RF Technology for Health Monitoring: Michael Leabman, CTO of Movano Health

      RF Technology for Health Monitoring: Michael Leabman, CTO of Movano Health

    • Cardiology
      Pencil-on-Paper Wearable Sensor

      Pencil-on-Paper Wearable Sensor

      Cell Culture Chamber Mimics Mechanical States of Disease

      Cell Culture Chamber Mimics Mechanical States of Disease

      Chest Wearable Provides Key Heart Measurements

      Chest Wearable Provides Key Heart Measurements

      Vein on a Chip Includes Flexible Valves

      Vein on a Chip Includes Flexible Valves

    • Surgery
      Smart Sutures Sense Inflammation, Deliver Drugs, Cells

      Smart Sutures Sense Inflammation, Deliver Drugs, Cells

      Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

      Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

      Soft Robotic Electrode Enables Minimally Invasive Placement

      Soft Robotic Electrode Enables Minimally Invasive Placement

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

    • Nanomedicine
      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

      Bottlebrush Particle for Synergistic Drug Combinations

      Bottlebrush Particle for Synergistic Drug Combinations

    • Military Medicine
      Wearable Can Take Multiple Sweat Samples

      Wearable Can Take Multiple Sweat Samples

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

    • Rehab
      Brain Decoder Spells Out Thoughts

      Brain Decoder Spells Out Thoughts

      Knitted Glove Massages the Hand to Treat Edema

      Knitted Glove Massages the Hand to Treat Edema

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Alzheimer’s Therapeutics Market to Reach USD 13.57 Billion By 2027 | Size, Share, Industry Analysis and Global Forecast to 2027

January 20th, 2021 Reports and Data Releases

Rise in investments for drug development biomarkers are expected to boost the global market growth.

Market size: 7.42 billion in 2019

Market Growth rate: 9.23%

Market trends: Advances in early detection and innovative techniques.

The Global Alzheimer’s Therapeutics Market is projected to reach USD 13.57 billion by 2027 from USD 7.42 billion in 2019 with a substantial CAGR of 9.2% through the forecast period. This can be primarily attributed to the increasing pipeline drug development, rise in investments for drug development biomarkers that are expected to boost the global market growth.

Alzheimer’s disease (AD) is a progressive neurological disorder in which the death of brain cells causes cognitive decline and memory loss. There is a steady decline in the thinking ability, social and behavioral skills due to atrophy of the brain. It is the most usual cause of dementia. AD also imposes a severe emotional and financial challenge to the patient’s family and society.

The disease is complicated, and so is the pathophysiology. Some studies have demonstrated the need to develop an efficient AD treatment, considering the rising cases worldwide. These disease has been studied for more than a century, but the only drugs currently in use are memantine and acteylcholiesterase inhibitors. These drugs alone provide significant improvement alone but do less to change the process of the disease.

Increasing advanced early detection diagnosis, specific drug discovery, and novel diagnostic techniques are some factors responsible for market growth based on statistics.

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/alzheimers-therapeutics-market

Further key findings:

  • Alzheimer’s is a type of dementia that affects behavior, thinking and memory of the patient. The development of the disease is steady, but the neurons associated with the learning sector of the cerebrum are diminished. It is the most common form of dementia in people above the age of 65.
  • Several trials are being undertaken to facilitate therapy based on the role of beta-amyloid in AD.
  • Therapeutics with cholinesterase inhibitors accounted for the highest market share of 38.85% by 2019. Neuropsychiatric symptoms like depression and agitation are assumed to improve.
  • Several types of research are carried out to facilitate treatment based on CT scans that often reveal specific characteristic changes associated with Alzheimer’s disease. These changes include expanded indentations in the tissues, the decline in the brain size and widening of cerebral ventricles.
  • A CT scan is a process in which multiple X-rays of the body are examined in a short time period from various angles. CT imaging produces images by estimating how easily the body and organs receive the x-rays. The CT scan diagnostic type is predicted to hit USD 4.95 billion by 2027.
  • In 2019, the pipeline drugs sector held a substantial market share of around 31.15%. It is estimated that the presence and production of pipeline drugs like LMTX by TauRx pharmaceuticals will have a significant affirmative impact on the industry’s growth. This medication is currently undergoing a Phase 3 trial to determine the safety and effectiveness in the treatment of mild to moderate AD.
  • In partnership with the Alzheimer’s Association, the Alzheimer’s Drug Discovery Foundation and Alzheimer’s Society UK launched a new initiative, Alzheimer’s combination therapy opportunities. This proposal is predicted to provide new opportunities for the industry.
  • Alzheimer’s Therapeutics market in the North American region held the highest market share of about 29.3% in 2019. Due to advanced healthcare services and infrastructure in the developed countries like US along with high purchase power for expensive drugs and reimbursement policies are expected to drive the market expansion.
  • The Asia Pacific region is expected to grow at a CAGR of 6.2% during the forecast period. The main reason for the market to flourish in this region is the high disposable income.

Key players:

  • Daiichi Sankyo Hoffmann-La Roche Ltd
  • Pfizer, Inc.,
  • Eli Lilly and Company
  • VTV Therapeutics
  • Eisai Co., Ltd.
  • TauRx Pharmaceuticals Ltd
  • Novartis AG
  • Lundbeck A/S
  • TauRx Therapeutics Ltd
  • Forest Laboratories, Inc.
  • AC Immun
  • Johnson & Johnson

Get a FREE Report Sample with Table of Contents and Figures @ https://www.reportsanddata.com/sample-enquiry-form/1364

For the purpose of this study, Reports and Data have segmented the Global Alzheimer’s Therapeutics Market on the basis of therapeutics, end-user, diagnostics type and region:

Therapeutics Outlook (Revenue, USD Million; 2017-2027)

  • NMDA receptor antagonist
  • Cholinesterase inhibitors
  • Pipeline Drugs

End-User Outlook (Revenue, USD Million; 2017-2027)

  • e-Commerce
  • Retail Pharmacies
  • Hospital Pharmacies

Diagnostics Type Outlook (Revenue, USD Million; 2017-2027)

  • Electroencephalography (EEG)
  • Magnetic resonance imaging (MRI)
  • Computed tomography (CT) scan
  • Lumbar puncture test
  • Others

Regional Outlook (Revenue, USD Million; 2017-2027)

North America

  • U.S.

Europe

  • Germany
  • U.K.

Asia Pacific

  • China
  • India
  • Southeast Asia

Latin America

  • Brazil

Middle East & Africa

Early Diners Are Offered Free Customization

Get Attractive Discount @ https://www.reportsanddata.com/discount-enquiry-form/1364

Ask for your specific company profile and country level customization on reports.

Get Insights into Our Other Trending HealthCare Reports:

Pressure Ulcers Treatment Market Size, Share & Analysis, By Product (Pressure Relief Devices, Wound Dressings, Wound Care Devices, Others), By Wound (Stage-1, Stage-2, Stage-3, Stage-4, Deep Tissue Injury), By End Use, By Region Forecasts To 2027

Facial Erythema Therapeutics Market Size, Trends & Analysis By Drug Type (Antibiotics, Antifungal, Antihistamines, Corticosteroids), By Mode of Administration (Topical and Oral), By Region, Forecast to 2027

Acromegaly Therapeutic Market Share, Growth & Analysis, By Product (Somatostatin analogs, GHRA), By End-User (Hospitals, Clinics), By Region, Forecast To 2027

About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:
John W
Head of Business Development
40 Wall St. 28th floor New York City
NY 10005 United States
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Facebook | LinkedIn | Twitter | Blogs

Sign up and submit a press release

Sponsored

Packaging Compliance Labs (PCL) Celebrates Site Expansion in Grand Rapids, MI

Novel Approach to Assessing Lung Function Enables Improved Detection, Diagnosis and Treatment Decisions in Subject Exposed to Military Burn Pits

U.S. Patent Office Grants Additional Patent Protection For  Exoskeleton Focal-Force Angioplasty Platform

U.S. Patent Office Grants Additional Patent Protection For Exoskeleton Focal-Force Angioplasty Platform

Reliefband® State of Nausea Study Reveals More Than Three-Quarters of Americans Are Prevented from Enjoying Life As a Result of Regular Nausea

Reliefband® State of Nausea Study Reveals More Than Three-Quarters of Americans Are Prevented from Enjoying Life As a Result of Regular Nausea

New AI-Powered Voice Controls Streamline Ultrasound Imaging with All Clarius Handheld Systems

New AI-Powered Voice Controls Streamline Ultrasound Imaging with All Clarius Handheld Systems

interviews & reviews
Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

Automated Computer Assistant for Kidney Transplant Rejection Diagnostics: Interview with Study Authors

RF Technology for Health Monitoring: Michael Leabman, CTO of Movano Health

RF Technology for Health Monitoring: Michael Leabman, CTO of Movano Health

AI’s role in Healthcare: Exclusive Interview with Catherine Estrampes, President & CEO at GE Healthcare

AI’s role in Healthcare: Exclusive Interview with Catherine Estrampes, President & CEO at GE Healthcare

Digital Self-Neuromodulation Therapy for PTSD: Interview with Oded Kraft, CEO of GrayMatters Health

Digital Self-Neuromodulation Therapy for PTSD: Interview with Oded Kraft, CEO of GrayMatters Health

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Imagene Profiles Cancer Biomarkers in Real Time

Imagene Profiles Cancer Biomarkers in Real Time

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email